Pharmaceutical Co., Ltd plans to hold the 2023 Annual General Meeting on 12 June 2024 and the Second Class H Stock Meeting in 2024 and will submit a number of company matters for shareholder approval. The agenda of the meeting includes the approval of the 2023 Board Report, the Board of Supervisors report, the financial statements and the profit distribution plan; the proposal to provide external guarantees to subsidiaries; the proposal to reappoint the firm of Takhine Accountants to audit the financial and internal control report in 2024; the proposal for a quota solution for the FX hedge business; the plan to reappoint the accounting firm of Takhine to audit the financial and internal control report for 2024; the proposal for a quota solution for the FX...Show More

Pharmaceutical Co., Ltd plans to hold the 2023 Annual General Meeting on 12 June 2024 and the Second Class H Stock Meeting in 2024 and will submit a number of company matters for shareholder approval. The agenda of the meeting includes the approval of the 2023 Board Report, the Board of Supervisors report, the financial statements and the profit distribution plan; the proposal to provide external guarantees to subsidiaries; the proposal to reappoint the firm of Takhine Accountants to audit the financial and internal control report in 2024; the proposal for a quota solution for the FX hedge business; the plan to reappoint the accounting firm of Takhine to audit the financial and internal control report for 2024; the proposal for a quota solution for the FX hedge business; and the plan to reappoint the accounting firm of Takhine to audit the financial and internal control report in 2024. DISCOVERY GOLD DIVIDENDS OF RMB9,8336 FOR A TOTAL OF APPROXIMATELY RMB28.8203 MILLION 1329.68; GUARANTEES FOR CERTAIN SUBSIDIARIES NOT EXCEEDING RMB115 BILLION; FOREIGN EXCHANGE HEDGING BUSINESS NOT EXCEEDING US$70 BILLION; PROPOSED AMENDMENTS TO COMPANY ARTICLES OF ASSOCIATION AND Shareholders' Meeting Rules; Adoption of the 2024 H-Share Reward Trust Scheme to authorize the Board of Directors to handle related matters; Proposed repurchase of A shares and/or H shares under certain conditions; Proposed capital reduction plan following share repurchase; Proposed amendments to independent directors, external guarantees, financial assistance and funding management system; Proposal to renew Appointment of Auditors for FY 2024; Proposes Foreign Exchange Hedge Business Quota Plan; Proposes Amendments to Registered Capital and Articles of Association; and Announces Notice of 2023 Annual General Meeting and Second Class H Stock Meeting 2024, Including Appointment of Proxy Form and Favorites in Shanghai Free Trade Zone Visit the hotel for meeting location details.